US Stock MarketDetailed Quotes

DXCM DexCom

Watchlist

80.040
+4.220+5.57%

Close Dec 20 16:00 ET

80.040
0.0000.00%

Post 20:01 ET

31.26BMarket Cap48.51P/E (TTM)

DexCom Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

DexCom Q3 2024 Earnings Date

Currency：USDOct 24, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	991.19M	994.20M	+3.01M
Beat Est.	+1.66%	+1.97%	+0.30%
EPS	0.41	0.34	-0.07
Miss Est.	+41.79%	+17.24%	-17.32%

Analyst Rating

Strong Buy

Dec 17, 2024

DexCom Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 1.030B	--
--	2024/Q4	-- / 1.096B	--
Oct 24, 2024	2024/Q3	994.200M / 991.187M	--
Jul 25, 2024	2024/Q2	1.004B / 1.037B	--
--	2024/Q1	921.000M / 910.902M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 1.030B--

--2024/Q4-- / 1.096B--

Oct 24, 20242024/Q3994.200M / 991.187M--

Jul 25, 20242024/Q21.004B / 1.037B--

--2024/Q1921.000M / 910.902M--

Unlock Free Earnings Estimates

Open Account

DexCom Earnings Reports

DexCom | 10-Q: Q3 2024 Earnings Report

Oct 24 17:14 ET

DexCom | 8-K: Dexcom Reports Third Quarter 2024 Financial Results

Oct 24 16:10 ET

DexCom | 10-Q: Q2 2024 Earnings Report

Jul 25 17:19 ET

DexCom | 8-K: Dexcom Reports Second Quarter 2024 Financial Results, Updates Guidance, and Announces $750 Million Share Repurchase Program

Jul 25 16:09 ET

Trending US Stocks

Symbol Mini Chart % Chg

Unlock the Full List

Analysis

Analyst Rating

Updated: Dec 17, 2024

Strong Buy

Buy
82.35%
Hold
17.65%
Sell
0.00%

Price Target

No Data

Investment Theme

Internet of Things

Intraday+2.05%